SP367PROBIOTICKD: A MONOCENTRIC, RANDOMIZED, OPEN-LABEL, PLACEBO-CONTROLLED STUDY TO REVEAL AND CORRECT GUT DYSBIOSIS IN EARLY CKD STAGES. (18th May 2018)